DiogenX is a biotechnology company that develops and commercializes therapeutics for the treatment of diabetes.
Business Model:
Revenue: $15k
Employees: 2-10
Address: 180 avenue du Prado
City: Marseille
State: other
Zip: 13008
Country: FR
DiogenX is a biotechnology company that develops and commercializes therapeutics for the treatment of diabetes.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2023 | Series A | $0 |
AdBio partners Boehringer Ingelheim Venture Fund Eli Lilly JDRF T1D Fund Omnes Capital Roche Venture Fund AdBio partners Boehringer Ingelheim Venture Fund Eli Lilly JDRF T1D Fund Omnes Capital Roche Venture Fund AdBio partners Boehringer Ingelheim Venture Fund Eli Lilly JDRF T1D Fund Omnes Capital Roche Venture Fund AdBio partners Boehringer Ingelheim Venture Fund Eli Lilly JDRF T1D Fund Omnes Capital Roche Venture Fund |
6/2020 | Seed Round | 3 | $5.1M |
AdBio partners Boehringer Ingelheim Venture Fund JDRF T1D Fund AdBio partners Boehringer Ingelheim Venture Fund JDRF T1D Fund |
6/2020 | Seed | $4.8M |
Advent France Biotechnology Boehringer Ingelheim Venture Fund JDRF T1D Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|